99 related articles for article (PubMed ID: 9379471)
1. Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients.
Cornejo-Juárez P; Vilar-Compte D; García-Horton A; López-Velázquez M; Ñamendys-Silva S; Volkow-Fernández P
BMC Infect Dis; 2016 Jun; 16():274. PubMed ID: 27286681
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance in Canada.
Conly J
CMAJ; 2002 Oct; 167(8):885-91. PubMed ID: 12406948
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance: the example of Staphylococcus aureus.
Lowy FD
J Clin Invest; 2003 May; 111(9):1265-73. PubMed ID: 12727914
[No Abstract] [Full Text] [Related]
4. Embracing ecology to limit antimicrobial resistance.
Nicolle L; Conly JM; MacDonald N
CMAJ; 2009 Feb; 180(4):371-2. PubMed ID: 19221342
[No Abstract] [Full Text] [Related]
5. Antibiotic resistance is the quintessential One Health issue.
Robinson TP; Bu DP; Carrique-Mas J; Fèvre EM; Gilbert M; Grace D; Hay SI; Jiwakanon J; Kakkar M; Kariuki S; Laxminarayan R; Lubroth J; Magnusson U; Thi Ngoc P; Van Boeckel TP; Woolhouse ME
Trans R Soc Trop Med Hyg; 2016 Jul; 110(7):377-80. PubMed ID: 27475987
[No Abstract] [Full Text] [Related]
6. How antibiotic resistance developed in the UK.
Jones T
Vet Rec; 2024 Mar; 194(5):193. PubMed ID: 38427419
[No Abstract] [Full Text] [Related]
7. Current guidelines for the treatment and prevention of nosocomial infections.
Bergogne-Bérézin E
Drugs; 1999 Jul; 58(1):51-67. PubMed ID: 10439929
[TBL] [Abstract][Full Text] [Related]
8. [Enterococci: acquired antibiotic resistance].
Alonso T; Pérez JL; Liñares J
Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):489-96. PubMed ID: 1489779
[No Abstract] [Full Text] [Related]
9. Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Fraise AP
J Med Microbiol; 1997 Jun; 46(6):447-9. PubMed ID: 9379471
[No Abstract] [Full Text] [Related]
10. Antibiotic resistance. Nosocomial gram-positive infection.
Cookson B; Morrison D; Marples R
J Med Microbiol; 1997 Jun; 46(6):439-42. PubMed ID: 9379468
[No Abstract] [Full Text] [Related]
11. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper .
Cohen AL; Calfee D; Fridkin SK; Huang SS; Jernigan JA; Lautenbach E; Oriola S; Ramsey KM; Salgado CD; Weinstein RA;
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):901-13. PubMed ID: 18808340
[No Abstract] [Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
Michel M; Gutmann L
Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
[TBL] [Abstract][Full Text] [Related]
13. Summaires for patients. Factors associated with the development of antibiotic-resistant bacteria.
Ann Intern Med; 2001 Aug; 135(3):S-27. PubMed ID: 11496847
[No Abstract] [Full Text] [Related]
14. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
May AK; Melton SM; McGwin G; Cross JM; Moser SA; Rue LW
Shock; 2000 Sep; 14(3):259-64. PubMed ID: 11028540
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
